Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

NCT01881126 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

NCT02097719 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

NCT06267274 ·Status: RECRUITING ·Phase: PHASE1

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

NCT01863953 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT01489670 ·Status: COMPLETED

A Study of Bimatoprost 0.01% in the Clinical Setting

NCT01814761 ·Status: COMPLETED

A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01632423 ·Status: COMPLETED

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma

NCT04890106 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction

NCT01547598 ·Status: COMPLETED ·Phase: PHASE4

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT01830140 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

NCT00652496 ·Status: COMPLETED ·Phase: PHASE2

Lumigan Versus Cosopt

NCT00273455 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®

NCT01664039 ·Status: COMPLETED ·Phase: PHASE4

A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01589510 ·Status: COMPLETED

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01628588 ·Status: COMPLETED

A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension

NCT03927443 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension

NCT02061683 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution

NCT01001195 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

NCT02507687 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT01068964 ·Status: COMPLETED ·Phase: NA

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

NCT01853085 ·Status: COMPLETED

A Study of LUMIGAN® RC in the Clinical Setting

NCT01833741 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

NCT04898387 ·Status: COMPLETED ·Phase: PHASE3